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generating sCTs which could be used for EBRT treatment 
planning for glioblastoma. Additional improvements of MRI 
protocols and patient fixation may reduce dosimetric 
differences between CT and sCT even further. 
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Purpose or Objective: Publications have shown the benefit 
of motion compensation (MC) of 4D CT to create a mid-
position CT for planning of lung tumours. The MC process 
creates a single sharp image in which all information of the 
4D scan is combined, improving signal to noise ratio, while 
the absence of motion blurring improves the identification of 
tumour and organ-at risk boundaries compared to a maximum 
intensity or average scan. Furthermore, margins to account 
for the residual respiration motion relative to the mid-
position scan can be small. Unfortunately, there are as yet no 
commercial solutions available to create such scans and their 
use is limited to a few hospitals. The aim of this work is to 
apply two commercial deformable registration systems, 
combined with open source software, to create mid-position 
scans, and to evaluate their performance for potential 
clinical use. 
 
Material and Methods: 4D phase sorted CT scans (Philips 
Brilliance, 10 frames) of 8 patients were selected. Tumour 
peak to peak motion had to exceed 8 mm and there was no 
selection on scan quality. Deformable registration between 
all frames and the first was performed using Elekta’s Admire 
and Mirada’s RTx. The deformation vector fields (DVFs) were 
exported in DICOM format. Using the open source Conquest 
DICOM server, the DVFs and 4D CT were converted into Nifti 
format. A script in the DICOM server then called open source 
command tools of NiftyReg to first calculate the average 
DVF. Subsequently for each frame, the average DVF was 
subtracted from the frame DVF and the CT frame was 
deformed with this DVF to the mid-position. The resulting MC 
4D data was written out for analysis. To provide a measure of 
quality of the MC process, the overall standard deviation of 
the difference of each MC CT frame with the average MC CT 
was calculated. 
 
Results: The quality of the MC scans made with the two 
commercial systems is evaluated in Fig. 1 both quantitatively 
(frame by frame) and visually (average scans). Because post-
processing was identical for both systems, only the quality of 
the DVF affects the results. Overall there is very little 
performance difference between the systems, with the 
average residual SD for both systems being within one 
Hounsfield unit. It is furthermore visible that certain frames 
(particularly 1, 2, 7 and 10) have a larger residual. These lie 
between in- and exhale and show a higher motion speed of 
the anatomical structures leading, on average, to more 
blurring and artefacts. 
 
 
Conclusion: Using a combination of commercial and open 
source software, mid-position CT scans were created. The 
performance of both commercial deformable registration 
packages was similar. For some motion compensated frames, 
registration performance is poorer. For practical 
implementation of the mid-position scan in our clinic, we 
propose to exclude such frames, likely leading to a more 
robust performance. 
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Purpose or Objective: 7 Tesla (7T) MRI has recently shown 
great potential for high-resolution soft-tissue neuroimaging 
and visualization of micro-vascularisation in glioblastoma 
(GBM). Its value for the delineation of GBM in radiation 
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therapy planning (RTP) has not yet been established. We 
hypothesize that 7T MRI allows for improved GTV delineation 
over 1.5T or 3T MRI and have designed a clinical study to 
investigate this. However, increases in power deposition, 
susceptibility artefacts and geometrical distortions could 
significantly compromise the quality and interpretability of 
7T MR images. In this study we aim for qualitative and 
quantitative assessment of these effects when incorporating 
7T MR images into the neurosurgical navigation and RTP 
software. 
 
Material and Methods: MR images were acquired with a 
Siemens Magnetom 7T whole-body scanner and a Nova 
Medical 32-channel head coil. 7T MRI pulse sequences were 
selected to visualize both intracranial anatomy and tumour 
(MP2RAGE) and perilesional edema (T2-SPACE, SPACE FLAIR). 
Moreover, multi-echo gradient recalled echo (GRE) T2*-
weighted images were selected to visualize 
microvascularisation. A pilot study with 3 healthy volunteers 
was performed to optimize the anatomical image contrast by 
tuning the pulse sequences and scan protocols. Subject 
tolerability and side effects were assessed after each scan. A 
new anthropomorphic 3D phantom (CIRS Model 603A) was 
used to assess the geometrical image accuracy. A study-
specific workflow for the transfer and processing of the 7T 
MR images from the scan facility to the RTP and neurosurgical 
navigation software was developed to enable integrating 
these images. 
 
Results: Images from the four pulse sequences could be 
acquired within 50 minutes. The scans were well tolerated. 
All three volunteers reported slight vertigo while being 
moved in and out of the scanner. No other side effects of the 
7T field were reported. Increased geometrical distortion was 
observed in the cortex in close proximity to air-filled cavities 
(fig 1). Regional loss of signal and contrast could be 
minimized by placing dielectric pads between the head and 
the coil. Regions of increased signal were identified in the 
occipital and temporal lobes caused by residual B1-
inhomogeneities. Flow-artefacts were observed near major 
intra-cranial vessels. Image transfer and processing did not 
degrade image quality. Overall system-related geometrical 
distortion was ≤2 mm. Detailed results of the geometric 
distortion analysis are reported in the phantom study by 
Peerlings et al. 
 
 
Conclusion: Integration of high quality and geometrically 
reliable 7T MR images into neurosurgical navigation and RTP 
software is technically feasible. Quantification of object-
related geometrical distortion needs further analysis before 
clinical implementation. 
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Purpose or Objective: Treatment planning in radiation 
therapy based on MRI requires the generation of pseudo CTs 
for correct attenuation and dose calculation. We present a 
new algorithm for pseudo-CT generation which is based on 
localised correlations of intensity values extracted from T1-
weighted and T2-weighted MRIs to CT HU values, which 
doesn’t require UTE MRI sequences. 
 
Material and Methods: The images of 15 patients, treated for 
brain tumors, were used to implement and test the 
algorithm. Each image sets includes a T1-weighted MRI, a T2-
weighted MRI (each acquired with 3D-MPRAGE protocol with 
i.v. contrast agent) and a CT. The latter two were 
coregistered for each patient to match the T1-weighted MRI. 
Both of the MRIs in each set were segmented into 6 different 
tissue classes (white matter, gray matter, cerebrospinal 
fluid, bone, skin/soft tissue and air) based on an SPM8 
segmentation algorithm 
(http://www.fil.ion.ucl.ac.uk/spm/software/spm8/). 
In order to generate a pseudo-CT for one individual, we used 
the image sets of the remaining 14 patients to generate the 
voxel-wise T1, T2 to CT correlations for each of the tissue 
classes. These were then used as two dimensional lookup 
tables to translate the T1 and T2 values of the individual to 
pseudo-HU values. After the application of post-processing 
steps including smoothing, we compared the generated 
pseudo-CT to the acquired CT, by calculating the bias and 
the mean absolute error of the difference. 
We repeated this procedure for all 15 patients. 
